Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial

NCT04332666 is registered in ClinicalTrials.gov with Erasme University Hospital as lead sponsor.

NCT NCT04332666
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04332666 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial
Lead sponsor
Erasme University Hospital
Phase
Phase 2/3
Overall status
Unknown status
Start date
December 30, 2021
Completion date
June 15, 2023
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus, coronavirus sars-associated as cause of disease classified elsewhere, respiratory failure, sars-cov-2